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Abstract
 .Niemann–Pick type C NPC is an autosomal recessive disease characterized by impaired cholesterol homeostasis due to
a defect in the intracellular transport of unesterified cholesterol. While accumulation of lysosomal cholesterol is the most
apparent microscopic finding, cholesterol has also been shown to accumulate in the trans-cisternae of the Golgi apparatus.
Caveolin-1, a cholesterol-binding protein that cycles between the Golgi apparatus and the plasma membrane, has been
hypothesized to participate in cholesterol transport. Using the BALBrc murine model for NPC disease, we found that the
expression of caveolin-1 in total liver homogenates from heterozygous and homozygous affected animals was altered.
 .Immunoblot analysis of liver homogenates from heterozygous mice revealed that caveolin-1 is significantly p-0.005
elevated, 4.9 fold, compared to normal mice. Total liver homogenates from homozygous affected mice also had a significant
 .p-0.05 increase in caveolin-1 expression, 1.6 fold, compared to normal mice. Immunohistochemical staining of liver
cross-sections revealed that the increased caveolin-1 was localized to sinusoidal endothelial cells in heterozygous mice. The
 .Triton insoluble floating fraction TIFF was isolated using liver from each genotype and analyzed for caveolin-1
 .expression. Caveolin-1 in the TIFF from heterozygous mice was significantly p-0.01 elevated, 1.8 fold, compared to
normal and homozygous affected animals; normal and homozygous affected animals, however, were not significantly
different from each other. The TIFF isolated from homozygous affected mice revealed a 15 fold increase in unesterified
cholesterol compared to the TIFF isolated from heterozygous and normal mice. In summary, these findings demonstrate an
altered expression of caveolin-1 in liver from heterozygous and homozygous NPC mice and increased concentration of
cholesterol from TIFF in homozygous affected NPC mice. The identification of these alterations in the TIFF suggests
involvement of detergent insoluble membrane structures, possibly caveolae andror detergent insoluble glycosphingolipid-
 .enriched complexes DIGs , in the cholesterol trafficking defect in this disorder. q 1997 Elsevier Science B.V.
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1. Introduction
Niemann–Pick type C disease is an autosomal
recessive lipid storage disorder of unknown etiology
w x1 . Hepatosplenomegaly, which begins in early
childhood, is usually the initial medical finding. Neu-
rologic dysfunction follows and is characterized by
vertical gaze palsy, ataxia, dystonia and dysarthria
w x1 . The neurological deterioration is relentless and
results in incapacitation by late adolescence. While
this condition has many clinical similarities to Nie-
mann–Pick types A and B, it has been determined
that the primary defect in NPC is not due to acid
w xsphingomyelinase deficiency 2 . Instead, LDL-de-
rived cholesterol accumulates within lysosomes and
the trans-Golgi cisternae and is not esterified at the
same rate as in normal cells indicating that there is a
defect in the intracellular transport of cholesterol
w x3,4 . Whether the defect in cholesterol trafficking is
primary, or whether the observed accumulation is due
to inhibition of trafficking by other as yet unidenti-
w xfied metabolites, is unknown 5 . Whatever the mech-
anism, a disruption of the intracellular movement of
unesterified cholesterol that results in decreased rates
of cholesterol esterification at the endoplasmic reticu-
lum.
Recently, there has been much interest in the
structure and function of detergent-insoluble mem-
brane fractions and their role in cholesterol
metabolism. The insoluble fraction isolated using Tri-
ton X-100 and sucrose density gradient ultracentrifu-
gation is called the Triton insoluble floating fraction,
w xor the TIFF 6,7 . The TIFF is believed to contain
plasma membrane caveolae, detergent insoluble
 .glycosphingolipid-enriched complexes DIGs and
 .Golgi-derived glycosylphosphatidylinositol GPI an-
w xchored protein enriched rafts 8,9 . Plasma membrane
caveolae are the best characterized of these three.
Caveolae are proposed to function in transcytosis and
potocytosis of extracellular compounds into and
across cells and are characterized by the presence of
w xa protein called caveolin 10–12 . Caveolin is an
avid, cholesterol-binding integral membrane protein
with a molecular weight of 20–25 kDa, capable of
forming multimers as high as 400 kDa. Three forms
of caveolin have been described, caveolin-1, cave-
olin-2 and caveolin-3, which differ in tissue-specific
w xexpression 13,14 . Caveolin-1 and caveolin-2 are
found together in the same tissues, but have different
functional interactions with heterotrimeric G proteins
and caveolin-3 expression is restricted to muscle
w x13,14 .
Recent studies have demonstrated that caveolin-1
is not restricted to plasma membrane caveolae. Cave-
olin-1 has also been identified on cytoplasmic trans-
w xport vesicles 15 , especially those vesicles that shut-
tle between the plasma membrane and the Golgi
w xapparatus 16 . Cholesterol oxidase treatment of intact
fibroblasts, which disrupts the cholesterol composi-
tion of the plasma membrane, stimulates the move-
ment of caveolin-1 containing vesicles between the
w xplasma membrane and the Golgi apparatus 17,18 . It
is possible that these caveolin-1 containing vesicles
transport cholesterol from the Golgi apparatus to the
plasma membrane to restore plasma membrane
cholesterol levels in response to cholesterol oxida-
tion. In addition, it has been shown that both endoge-
nously synthesized and LDL-derived cholesterol are
transported to caveolae and that cholesterol effluxes
w xfrom fibroblasts via caveolae 19 . These findings
strongly suggest a relationship between plasma mem-
brane caveolae and cholesterol trafficking. Because
of this relationship, we determined the expression of
caveolin-1 and cholesterol levels in the TIFF isolated
from liver from the murine NPC animal model. We
have found alterations in caveolin-1 expression and
unesterified cholesterol levels that prompt us to con-
clude that a component of the TIFF is affected by the
NPC intracellular cholesterol trafficking defect.
2. Methods
2.1. Animals
Two breeding pairs of BALBrc heterozygous mice
were obtained as a gift from Dr. Peter Pentchev of
the National Institutes of Health. These mice were
bred to produce affected offspring and additional
heterozygotes. Homozygous mice for the NPC pheno-
type were identified by tremor of the fore-limbs when
picked up by the tail and by severe ataxia. A separate
colony of homozygous normal BALBrc mice were
established. Animals were euthanized by cervical dis-
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location and livers were removed and stored at y708C
until analysis. Within the specified genotypes of
mouse livers analyzed, both males and females were
represented. Homozygous normal mice were eutha-
nized between the ages of 1.5–12 months. Homozy-
gous affected mice were euthanized between the time
 . of diagnosis ; 1.5 months and death ; 2.5
.months . Heterozyous mice were euthanized between
the ages of 3–12 months the least amount of time
.necessary to determine carrier status by breeding .
Therefore, livers derived from these mice were rela-
tively age matched. Animals were maintained at the
University of Arizona Animal Care facility PHS
.Assurance No. A-3248-01 on mouse chow contain-
ing 6% fat and water ad libitum.
2.2. Reagents
Cholesterol, Triton X-100, Mes, sodium chloride,
sucrose, EDTA, Tris, PMSF, pepstatin A, leupeptin,
anti-a-tubulin IgG and anti-Golgi 58K IgG were
purchased from Sigma Chemical Company St. Louis,
.MO . Glacial acetic acid, hexane, isopropanol and
chloroform were purchased from Fisher Scientific
 .Pittsburgh, PA . Ether was obtained from Aldrich
 .Chemical Company Milwaukee, WI . BCA protein
assay reagent and Supersignal Substrate for western
blotting were purchased from Pierce Chemical Co.
 .Rockford, IL . Cholesterol oxidase was purchased
 .from Calbiochem La Jolla, CA and horseradish
peroxidase from Boehringer Mannheim Indianapolis,
.IN . Mouse anti-caveolin-1 IgG and rabbit anti-in-
sulin receptor IgG were purchased from Transduction
 .Laboratories Lexington, KY and peroxidase-con-
jugated anti-rabbit IgG and anti-mouse IgG were
purchased from Kirkegaard and Perry Laboratories
 .Gaithersburg, MD . Anti-lysosomal glycoprotein of
 .120 kDa anti-lgp120 was a gift of Dr. William
w xDunn 20 .
2.3. Purification of the TIFF
The TIFF from mouse liver was purified essen-
w xtially as outlined by Chang et al. 21 . One-half of a
mouse liver was minced using a razor blade, followed
by homogenization in 10 ml of ice-cold buffer A
0.025 M Mes, pH 6.5, 1 mM EDTA, 10 mM each of
.PMSF, pepstatin, leupeptin and aprotinin using a
motor-driven Dounce homogenizer. This homogenate
was centrifuged at 500=g for 10 min to remove
nuclei and cell debris. The resulting post-nuclear
supernatant was centrifuged at 100,000=g for 1 h to
obtain a pellet representing a total membrane prepara-
tion. This pellet was solubilized in 2 ml of ice-cold
buffer A containing 150 mM NaCl and 1% Triton
 .X-100 buffer B using needle aspiration.
A sucrose step gradient was generated with 1.5 ml
42% sucrose, 3.0 ml 25% sucrose and 3.5 ml 15%
sucrose in buffer B containing 0.5% Triton X-100 at
48C. Triton X-100 solubilized membranes were lay-
ered on the sucrose gradient and centrifuged at
100,000=g for 2 h at 48C. The TIFF migrated to the
15–25% sucrose interface and the opalescent inter-
face was collected directly using needle aspiration
 .1.5 ml . Collected fractions were concentrated using
 .Centricon-10 concentrators Amicon, Beverly, MA
in preparation for sodium dodecylsulfate polyacryl-
 .amide electrophoresis SDS-PAGE and cholesterol
determination.
2.4. Immunoblotting
Samples were separated using 10% SDS-PAGE
under reducing conditions and transferred to a nitro-
cellulose membrane. Immunoblot buffer 0.010 M
sodium phosphate pH 7.4, 0.150 M NaCl, 0.05%
.Tween 20 and 4% non-fat dry milk was used for
blocking nonspecific sites on the nitrocellulose mem-
brane by immersion for 2 h at room temperature. The
blots were then incubated with mouse anti-caveolin-1
 .IgG 1:500 dilution in blocking buffer overnight at
48C. Blots were washed three times for 10 min each
using blocking buffer, then incubated with peroxidase
conjugated to goat-anti-mouse IgG 1:5000 dilution
.in blocking buffer for 1 h at room temperature. The
blots were washed three times for 10 min each using
blocking buffer followed by incubation for 5 min in
Supersignal Substrate solution as indicated by the
 .manufacturer Pierce Chemical Co., Rockford, IL to
detect immunoreactive protein using enhanced chemi-
 .luminescence ECL . Immunoblots probed with dif-
ferent primary antibodies were performed in a similar
manner. Protein bands were visualized using a Bio-
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Rad GS-525 Molecular Imaging System equipped
with a CH-Imaging Screen. Chemiluminescence was
allowed to occur for 2 h and then each band within a
series of experiments was quantitated using an equal
area. Background counts were subtracted from each
respective sample and results reported as countsrmg
protein.
2.5. Immunohistochemistry
Liver explants were fixed in freshly depolymerized
3% paraformaldehyde in phosphate buffered saline
 .PBS for 2 h at room temperature, washed, embed-
ded in paraffin. After rehydration of the sections on
slides, sections were blocked for 30 min at room
temperature with 10% goat serum in PBS blocking
.buffer and incubated with anti-caveolin-1 antibody
diluted 1:20 in blocking buffer for 2 h at room
temperature. After washing, sections were incubated
for 30 min at room temperature with anti-mouse
antibody conjugated to Cy-5 Jackson Immunochemi-
.cals, West Grove, Pennsylvania diluted 1:150 in
blocking buffer followed by mounting in Moviol.
Fluorescent images were obtained using a Leica TCS
4D laser scanning confocal microscope Arizona Re-
search Laboratory, Division of Biotechnology, Uni-
.versity of Arizona using a 100= , NA 1.3 oil im-
mersion objective. Single channel recording was per-
formed using an excitation wavelength of 647 nm
and a 690 nm long pass filter. Images were obtained
using identical laser and photomultiplier settings for
comparison of fluorescent intensities.
2.6. Cholesterol determination
Cholesterol concentrations were determined using
the cholesterol oxidase method of Heider and Boyett
w x22 . Briefly, the TIFF was extracted with hexane:iso-
 .propanol 3:2 for 1 h, followed by centrifugation to
pellet the protein. The organic solution was removed,
dried and spotted onto a thin-layer chromatography
 .plate Redi-Plate, Silica Gel G, Fisher Scientific . To
separate neutral lipids, hexane:ethyl ether:glacial
 .acetic acid 100:30:1.1 was used as the mobile phase.
After staining with iodine vapors, the unesterified
cholesterol was scraped from the plate, extracted with
100% hexane and dried in a glass tube. To each tube,
 0.4 ml of assay reagent 0.1 ml cholesterol oxidase 8
.  .Urml , 0.1 ml peroxidase 3000 Urml , 1.0 ml of
 .p-hydroxyphenylacetic acid 1.5 mgrml and 8.8 ml
.of 0.05 M sodium phosphate buffer pH 7.0 was
added and incubated for 20 min at room temperature.
The reaction was terminated by adding 0.8 ml of 0.5
N NaOH. A Perkin–Elmer Model LS-40 fluores-
cence spectrometer excitation at 325 nm and emis-
.sion at 415 nm was used for measuring fluorescence.
Unknown cholesterol concentrations were determined
from known cholesterol standards using linear regres-
sion.
Table 1
Presence of specific marker proteins in liver homogenates and respective isolated TIFF. Liver homogenates and corresponding isolated
 .TIFF from four known homozygous affected mice were prepared as described in Section 2. Equal amounts of protein 20 mg from both
the homogenate and isolated TIFF were subjected to 7% or 10% depending on the molecular weight of the marker protein being
.quantitated SDS-PAGE and transferred to a nitrocellulose membrane in preparation for immunoblot analysis. Antibodies directed against
each of the respective marker proteins were utilized at the manufacturers suggested dilution in conjunction with the appropriate
peroxidase-conjugated goat secondary antibody. Immunoblots were detected using ECL and quantitated using molecular imaging after
several hours of exposure. Homogenate and isolated TIFF protein samples were run in parallel. Data is represented as the mean"standard
deviation of four different liver homogenates and corresponding isolated TIFF
Marker protein Homogenate Isolated TIFF Presence in TIFF
 .  .  .countsrmg protein countsrmg protein % of homogenate
Caveolin-1 21.1"4.4 135.6"22.4 641.3"106.1
Alpha tubulin 9.7"1.1 0.2"0.2 2.3"1.8
Golgi 58 kDa protein 53.1"12.1 6.6"5.6 12.4"10.5
Insulin receptor 59.0"18.1 3.4"2.0 5.7"3.4
Lysosomal glycoprotein of 120 kDa 8.7"1.4 0.2"0.3 2.3"3.5
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Fig. 1. Representative autoradiogram of liver homogenates pre-
pared from a single homozygous normal, heterozygous and NPC
homozygous affected mouse probed for caveolin-1 expression.
 .Equal amounts of protein 50 mg from each sample was sub-
jected to 10% SDS-PAGE, then transferred to a nitrocellulose
membrane and probed with mouse anti-caveolin-1 IgG as de-
scribed in Section 2. Immunoreactive proteins were detected
using peroxidase-conjugated rabbit anti-mouse secondary anti-
body and developed using ECL and conventional autoradiog-
raphy. Caveolin-1 is approximately 22 kDa. Higher molecular
weight immunoreactive proteins detected on this autoradiogram
represent by both heteromeric and homomeric caveolin-1 com-
w xplexes as previously described in the literature 32 . qrq
homozygous normal, " heterozygous and yry homozygous
affected.
2.7. Statistical analysis
All quantitative data is represented as the mean"
standard deviation of the indicated number of sam-
ples. Significant differences between groups of data
 .P-0.05 were determined using a two-tailed t-test
assuming equal variance.
Fig. 2. Quantitation of caveolin-1 expression in liver ho-
mogenates and respective isolated TIFF. Equal amounts of pro-
 . tein 20 mg from four sets of mice one set equaling a homozy-
.gous normal, a heterozygous and a homozygous affected mouse
were subjected to 10% SDS-PAGE, then transferred to a nitro-
cellulose membrane and probed with mouse anti-caveolin-1 IgG
in Section 2. Immunoreactive proteins were detected using perox-
idase-conjugated rabbit anti-mouse secondary antibody and quan-
 .titated using ECL and molecular imaging. A Liver ho-
 .mogenates. B Isolated TIFF from each respective liver ho-
mogenate. All samples were run in parallel with the background
counts subtracted from each respective sample and then normal-
ized to protein. Shown is the mean"standard deviation from
 .each set of samples. l Statistically significant difference be-
tween heterozygous mice and both homozygous normal and
 .  .homozygous affected mice p-0.0005 . % Statistically signif-
icant difference between homozygous normal and homozygous
 .affected mice p-0.05 .
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3. Results
3.1. Characterization of the TIFF
The method used for the isolation of the TIFF was
developed to isolate caveolae from smooth muscle
w xcells 21 . To determine if this method could be used
with liver homogenates, we analyzed the TIFF ob-
tained from liver homogenates for intracellular marker
proteins. We assayed four marker proteins, the in-
sulin receptor, a-tubulin, lysosomal glycoprotein of
120 kDa and Golgi protein of 58 kDa, for depletion
or enrichment of specific marker proteins compared
to the total homogenate by immunoblotting and en-
 .hanced chemiluminescence Table 1 . The amount of
the insulin receptor, a noncaveolae plasma membrane
protein, in the TIFF was only 5.7"3.4% of the
amount measured in the total homogenate. The TIFF
levels of a-tubulin, a cytoplasmic protein that forms
microtubules, was 2.3"1.8% that measured in the
total homogenate. The lysosomal membrane glyco-
protein, lgp120, was 2.3"3.5% of the amount mea-
sured in the total homogenate and the Golgi 58 kDa
protein, was 12.4"10.5% of that measured in the
total homogenate. The low amounts of these markers
in the TIFF indicates that there is not significant
contamination of the TIFF with components from
these intracellular organelles.
We next determined the enrichment of caveolin-1
in the TIFF compared to total liver homogenate. We
found that caveolin-1 in the TIFF was significantly
 .p-0.0001 enriched, 6.4"1.1 fold, compared to
 .total homogenates from the same animals Table 1 .
This indicates that caveolin-1 containing cell frac-
tions, including caveolae, are enriched using this
technique and that the degree of caveolin-1 enrich-
ment is similar to the 5 fold enrichment obtained by
w xChang et al. 21 using this technique. This enrich-
ment of caveolin-1 in the TIFF is in direct contrast to
the depletion of the other marker proteins.
Fig. 3. Immunohistochemical staining of liver sections derived
from a single homozygous normal, heterozygous and homozy-
gous affected mouse for caveolin-1. Immunohisto-chemistry us-
ing mouse anti-caveolin-1 IgG and imaging using confocal mi-
 .croscopy are described in detail in Section 2. A Homozygous
normal liver sections exhibit staining of only the sinusoidal
surface represented by liver endothelial cells, consistent with
findings that indict the lack of caveolin-1 expression in hepato-
 .cytes. B Heterozygous liver sections show a markedly increased
 .level of caveolin-1 expression at the sinusoidal surface. C
Homozygous affected liver sections show an intermediate level
of caveolin-1 expression at the sinusoidal surface.
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3.2. Ca˝eolin-1 expression in the total li˝er ho-
mogenate and in the TIFF
Although caveolin-1 has not been detected in hepa-
tocytes, endothelial cells contain large numbers of
caveolae and have been shown to contain significant
w xlevels of caveolin 23 . Since endothelial cells lining
the hepatic sinusoids comprise approximately 15–
w x20% of the cells of the liver 24 and endothelial cells
perform a critical role in cholesterol homeostasis
w x25–27 , we analyzed caveolin-1 levels in liver ho-
mogenates from four sets of mice one set equal to a
homozygous normal, a heterozygous and a homozy-
.gous affected mouse . Fig. 1 is a representative auto-
radiogram from one set of animals. Compared to the
expression of caveolin-1 in normal mice, heterozy-
 .gous mice expressed significantly p-0.0005 ele-
 .  .vated amounts 4.9 fold of this protein Fig. 2A .
Liver from homozygous affected animals also ex-
 .pressed significantly p-0.05 elevated amounts of
 .caveolin-1 1.6 fold when compared to the expres-
 .sion of caveolin-1 in normal mouse liver Fig. 2A .
Caveolin-1 levels were next determined in the TIFF
isolated from liver of each genotype. Caveolin-1 in
the TIFF from heterozygous animals had increased
 .amounts, 1.8 fold p-0.0001 , compared to levels
 .in the TIFF from normal animals Fig. 2B . However,
the levels of caveolin-1 in TIFF from homozygous
affected and homozygous normal animals were not
significantly different from each other.
3.3. Immunohistochemistry
Because the immunoblotting results demonstrated
altered caveolin-1 expression in liver homogenates
from heterozygous mice, we investigated the distribu-
tion of caveolin-1 expression in liver sections in
order to determine the location of this protein Fig.
.3 . Fig. 3A is a liver section from a homozygous
normal mouse and demonstrates punctate staining
along the hepatic sinusoids. Heterozygous animals
showed a similar localization but a striking increase
 .in staining Fig. 3B . This staining pattern is consis-
tent with expression of caveolin-1 in sinusoidal en-
dothelial cells. Fig. 3C is a section from a homozy-
gous affected mouse and shows some increase in
sinusoidal staining but not to the degree seen in
heterozygous animals.
Fig. 4. Concentration of unesterified cholesterol measured in
isolated TIFF derived from the livers of homozygous normal,
heterozygous and homozygous affected mice. TIFF was isolated
from the homogenate of livers derived from four sets of mice
one set equaling a homozygous normal, heterozygous and ho-
.mozygous affected mice . Unesterified cholesterol was extracted
from each liver derived TIFF, isolated using conventional TLC
and quantitated using the cholesterol oxidase method described in
the Section 2. Data represents the mean" standard deviation
concentration of unesterified cholesterol normalized to protein.
 .UCsunesterified cholesterol. l Statistically significant differ-
 .ence p-0.005 between homozygous affected compared to
both the homozygous normal and heterozygous affected mice.
3.4. Determination of cholesterol in the TIFF
We next determined unesterified cholesterol levels
 .in the TIFF from each of the genotypes Fig. 4 .
Cholesterol in the TIFF isolated from homozygous
 .affected animals was significantly p-0.005 en-
riched 106"34 mg unesterified cholesterolrmg
.protein compared to cholesterol in the TIFF from
homozygous normal animals 7.71"0.26 mg unes-
.terified cholesterolrmg protein . This represents an
approximate 15 fold increase in the concentration of
unesterified cholesterol within this isolated fraction.
In contrast, cholesterol in the TIFF from heterozy-
gous animals 6.45"2.33 mg unesterified choles-
.terolrmg protein was not significantly different from
normal animals in agreement with similar cholesterol
levels measured in total liver homogenates between
 .these two genotypes data not shown .
4. Discussion
In this study, we measured the levels of caveolin-1
in liver homogenates and the TIFF and cholesterol
levels within the TIFF in the murine BALBrc NPC
animal model. We found alterations in expression of
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caveolin-1 in heterozygous and homozygous affected
mice using immunoblotting and immunohistochem-
istry. We also found elevated levels of unesterified
cholesterol in the TIFF obtained from homozygous
affected mouse liver. These findings allow us to
further define the cholesterol trafficking defect in
NPC.
The explanation for increased expression of cave-
olin-1 is unknown. The source of the caveolin-1 is
likely sinusoidal endothelial cells based on the im-
munohistochemical staining and since hepatocytes do
w xnot express caveolin-1 mRNA 13 . Endothelial cells
have been shown to function as mediators of the
w xterminal steps of reverse cholesterol transport 27
and it is possible that this process is disrupted in
NPC. The increased expression of caveolin-1 may be
representative, therefore, of a compensatory mecha-
nism in response to this disruption. Support for such
compensation is suggested by the lack of accumula-
tion of unesterified cholesterol in either liver ho-
mogenates or the TIFF in heterozygous animals, but
increased caveolin-1 levels. A corollary conclusion of
this finding is that the increases in caveolin-1 found
in these experiments are not secondary to increased
cholesterol since cholesterol levels are normal in
heterozygous animals. What is perplexing, however,
are the results that demonstrate increased caveolin-1
expression in homozygous affected animals, but not
to the extent measured in heterozygous animals. We
would have anticipated that the caveolin-1 elevations
would be greater in homozygous than heterozygous
animals because of the more profound disruption of
cholesterol transport.
Hepatocytes have been clearly demonstrated by
microscopic examination to accumulated lipid in NPC
w x w x1 , yet they do not contain caveolin-1 13 . So while
caveolin-1 expression may reflect the disruption of
cholesterol trafficking in endothelial cells, alternative
explanations are required for hepatocytes. One possi-
ble explanation is that hepatocytes contain a deter-
gent insoluble glycosphingolipid-enriched domain, a
DIG, that does not contain caveolin-1 but is affected
analogous to the caveolin-1 containing component in
endothelial cells. An alternative explanation is the
NPC defect in endothelial cells compromises a neces-
sary interaction with hepatocytes resulting in defec-
tive hepatocyte function. Further investigation is
needed to delineate between these possibilities.
The cellular components represented within the
TIFF and its involvement in the NPC defect is un-
known, but possible sites include detergent-insoluble
microdomains of the plasma membrane or the Golgi
apparatus. NPC fibroblasts have been shown to have
a decreased rate of transport of unesterified choles-
terol to the plasma membrane and decreased avail-
ability of plasma membrane cholesterol for desorp-
w xtion into the media 28 . When NPC fibroblasts are
incubated with nonlipoprotein cholesterol, there is
inefficient internalization of the cholesterol from the
plasma membrane to the endoplasmic reticulum for
w xesterification by ACAT 29 . Treatment of NPC fi-
broblasts with sphingomyelinase results in insuffi-
cient translocation of plasma membrane cholesterol
to the endoplasmic reticulum for esterification by
w x w xACAT 30 . Previous studies 3,31 using transmis-
sion and freeze-fracture electron microscopy demon-
strate distention and accumulation of cholesterol in
the trans-Golgi cisternae. Recently, it has been shown
that oxidation of plasma membrane cholesterol using
cholesterol oxidase causes a redistribution of cave-
olin-1 from the plasma membrane to the Golgi appa-
w xratus 17 . Perhaps the accumulation of unesterified
cholesterol within the trans-Golgi cisternae is due to
disruption in this vesicle-mediated process.
A critical finding of our investigations was that the
TIFF from homozygous affected animals accumu-
lated significant amounts of unesterified cholesterol
compared to the TIFF from normal and heterozygous
animals. We do not believe that this elevation is due
to contamination of the TIFF from known choles-
terol-rich organelles present as a result of the disease,
since marker proteins from several organelles were
not significantly represented in the TIFF. Most im-
portantly, a lysosomal marker protein, referred to as
 .lysosomal glycoprotein of 120 kDa lgp-120 , was
not significantly represented in this fraction, therefore
indicating that lysosomal cholesterol is not responsi-
ble for contaminating this TIFF. It is very possible,
however, that the TIFF contains detergent insoluble
membrane domains from as yet uncharacterized or-
ganelle membranes enriched in cholesterol as a result
of the defective trafficking in NPC.
Our findings of altered caveolin-1 expression and
increased unesterified cholesterol in the TIFF from
homozygous animals prompt us to consider that a
component of the TIFF, whether from caveolae de-
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rived from endothelial cells, DIGs from both endothe-
lial cells and hepatocytes, or a yet undefined compo-
nent of TIFF, is involved in the cholesterol traffick-
ing defect in NPC. Further investigation is necessary
to identify conclusively what caveolin-1 containing
TIFF component is involved in the NPC cholesterol
trafficking defect.
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